Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System

TerminatedOBSERVATIONAL
Enrollment

182

Participants

Timeline

Start Date

October 16, 2020

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Multiple SclerosisClinically Isolated Syndrome
Interventions
DEVICE

MSPT

The MS Performance Test (MSPT) software tool and accompanied hardware is an iPad®-based assessment tool, developed via collaboration between Biogen and the Cleveland Clinic Mellen Center, and designed to objectively quantify the major motor, visual and cognitive function data, and quality of life outcomes, associated with MS and related disorders.These assessment modules of the MSPT are self-administered by MS patients at the point of care and incorporate and expand upon previously validated measures of the MSFC.

Trial Locations (1)

3010

Inselspital Bern, Ambulantes Neurozentrum, Bern

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT04599023 - Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System | Biotech Hunter | Biotech Hunter